Position
Creative Planning in Rapport Therapeutics, Inc.
Back to the book · All holders of RAPP
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $11.6K$30.34 → $31.29
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 12.2K | $370.5K | — | — | — | 0.0% |
| Q1 2026 | 15.5K | $485.6K | $31.29 | $11.6K | $103.5K | 0.0% |